FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) filed by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture
• Peyronie Disease

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

SUPPL AP for XIAFLEX (COLLAGENASE CLOSTRIDIUM HISTOLYTICUM)